Literature DB >> 30666407

Epidemiological screening and xenomonitoring for human lymphatic filariasis infection in select districts in the states of Maharashtra and Karnataka, India.

Vishal Khatri1, Nitin Amdare2, Nikhil Chauhan1, Namdev Togre3, Maryada V Reddy3, Subhash L Hoti4, Ramaswamy Kalyanasundaram5,6.   

Abstract

Lymphatic filariasis (LF) is a mosquito-transmitted tropical neglected parasitic infection that currently affects over 120 million people around the world and another 856 million people are at risk of acquiring the infection. Mass Drug Administration (MDA) spearheaded by the World Health Organization is the only current strategy to control this infection in endemic areas. In this study, we performed an epidemiological survey in select regions in the southern parts of India to determine the current status of LF infection in subjects. Night blood samples were collected from 916 subjects after proper consent and were screened for the presence of circulating microfilariae of Wuchereria bancrofti in their peripheral blood. Our results showed the presence of 51 (5.56%) cases of human LF infection in the surveyed areas including new cases for LF, which were not recorded previously. Given the presence of new cases of LF infections, we trapped mosquitoes from these regions and screened for the presence of W. bancrofti L3 specific Ssp1 DNA repeat sequences by PCR. Our results confirmed the presence of LF infection in the mosquitoes collected from six out of nine districts that we surveyed. These findings confirm active transmission of LF infection in all of the areas that we surveyed, despite several years of MDA treatment. The findings in this study suggest potential reemergence of LF infection in most of the areas we surveyed and warrants for a more stringent strategy for controlling LF in these endemic areas.

Entities:  

Keywords:  India; Lymphatic filariasis; Mosquitoes; Night blood screening; PCR; Reemergence of infection

Mesh:

Year:  2019        PMID: 30666407      PMCID: PMC6401222          DOI: 10.1007/s00436-019-06205-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  22 in total

1.  Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.

Authors:  B V Babu; S K Kar
Journal:  Trop Med Int Health       Date:  2004-06       Impact factor: 2.622

2.  A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India.

Authors:  Ashwini Kumar; Pawan Kumar; Kondagunta Nagaraj; Divakar Nayak; Lena Ashok; K Ashok
Journal:  J Vector Borne Dis       Date:  2009-09       Impact factor: 1.688

Review 3.  Lymphatics in human lymphatic filariasis: in vitro models of parasite-induced lymphatic remodeling.

Authors:  Sasisekhar Bennuru; Thomas B Nutman
Journal:  Lymphat Res Biol       Date:  2009-12       Impact factor: 2.589

Review 4.  Lymphatic filariasis in India: epidemiology and control measures.

Authors:  Khk Raju; P Jambulingam; S Sabesan; P Vanamail
Journal:  J Postgrad Med       Date:  2010 Jul-Sep       Impact factor: 1.476

5.  A survey of bancroftian filariasis for microfilariae & circulating antigenaemia in two villages of Madhya Pradesh.

Authors:  D Das; S Kumar; P K Sahoo; A P Dash
Journal:  Indian J Med Res       Date:  2005-06       Impact factor: 2.375

6.  Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment.

Authors:  Anne E Schwab; Daniel A Boakye; Dominique Kyelem; Roger K Prichard
Journal:  Am J Trop Med Hyg       Date:  2005-08       Impact factor: 2.345

7.  The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.

Authors:  Maged El-Setouhy; Khaled M Abd Elaziz; Hanan Helmy; Hoda A Farid; Hussein A Kamal; Reda M R Ramzy; William D Shannon; Gary J Weil
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

8.  Xenomonitoring of Wuchereria bancrofti and Dirofilaria immitis infections in mosquitoes from American Samoa: trapping considerations and a comparison of polymerase chain reaction assays with dissection.

Authors:  Eric W Chambers; Shannon K McClintock; Melissa F Avery; Jonathan D King; Mark H Bradley; Mark A Schmaedick; Patrick J Lammie; Thomas R Burkot
Journal:  Am J Trop Med Hyg       Date:  2009-05       Impact factor: 2.345

9.  Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme.

Authors:  K D Ramaiah; B Thiruvengadam; P Vanamail; S Subramanian; S Gunasekaran; N Nilamani; P K Das
Journal:  Trop Med Int Health       Date:  2009-06-22       Impact factor: 2.622

10.  Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti.

Authors:  A E Schwab; T S Churcher; A J Schwab; M-G Basáñez; R K Prichard
Journal:  Parasitology       Date:  2006-07-12       Impact factor: 3.234

View more
  2 in total

Review 1.  The use of molecular xenomonitoring for surveillance of mosquito-borne diseases.

Authors:  Mary M Cameron; Anita Ramesh
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-12-28       Impact factor: 6.237

2.  De novo Assembly of the Brugia malayi Genome Using Long Reads from a Single MinION Flowcell.

Authors:  Joseph R Fauver; John Martin; Gary J Weil; Makedonka Mitreva; Peter U Fischer
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.